GlaxoSmithKline (GB:GSK) has released an update.
GlaxoSmithKline (GSK) PLC has reported multiple acquisitions of its ordinary shares by key senior executives and persons closely associated with them, following the reinvestment of dividends paid out on July 11, 2024. The transactions took place on the London Stock Exchange on July 16, 2024, with shares acquired at a price of £14.9318 each. This financial activity showcases the continued investment by GSK’s leadership in the company’s stock, reflecting their confidence in its performance.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.
